Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.6033
H.R.6033: Adding Middle East Respiratory Syndrome to the FDA Priority Review Voucher Program Act
About This Bill
- This bill was introduced in the 114th Congress
- This bill is primarily about health
- Introduced Sept. 14, 2016
- Latest Major Action Sept. 14, 2016
- See the one similar bills introduced in other congresses.
Bill Sponsor
Bill Summary
Adding Middle East Respiratory Syndrome to the FDA Priority Review Voucher Program Act This bill amends the Federal Food, Drug, and Cosmetic Act to add Middle East respiratory syndrome to the list of tropical diseases under the priority review voucher program, which awards a voucher to the sponsor of a new drug or biological product that is approved to prevent or treat a tropical disease. (A voucher entitles the holder to have a future new...
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
Sept. 14, 2016 |
Referred to the House Committee on Energy and Commerce.
|
Sept. 14, 2016 |
Introduced in the House by Scott Peters (D-Calif.) |